Initial MRI findings predictive of a pathological complete response to neoadjuvant treatments in HER2-positive breast cancers
Anne Ribrag(Institut Curie), A. Tardivon(Université Paris Sciences et Lettres), Toulsie Ramtohul(Université Paris Sciences et Lettres), Émilie Lissavalid(Institut Curie), Lounes Djerroudi(Memorial Sloan Kettering Cancer Center), Juliette Fayard(Institut Curie), Mathilde Saint Ghislain(Institut Curie)
Cited by 0
Related Papers
COVID-19 in breast cancer patients: a cohort at the Institut Curie hospitals in the Paris area
|Breast Cancer Research|2020|125
Multiparametric MRI and Radiomics for the Prediction of HER2-Zero, -Low, and -Positive Breast Cancers
|Radiology|2023|122
Characteristics and Outcome of SARS-CoV-2 Infection in Cancer Patients
|JNCI Cancer Spectrum|2020|60
Prospective Evaluation of Ultrafast Breast MRI for Predicting Pathologic Response after Neoadjuvant Therapies
|Radiology|2022|44
Checkpoint inhibitors and gastrointestinal immune-related adverse events
|Current Opinion in Oncology|2016|40